ZTOX Insights

RAGHUSYN

RAGHUSYN

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Raghuvir Synthetics (RAGHUSYN): Board Meeting

Board Meeting 1) Audited Standalone and Consolidated financial results for the quarter and Year ended 31st March 2026. As per Regulation 33 of Listing Regulations, the Financial Results, statement of Assets & Liabilities and Audited Report with Declaration for Non-Applicability of Statement of Impact of Audit Qualification. 2) Appointed M/s. Ashok K. Bhatt & Co. as the Internal Auditor of the Company for the FY 2026-2027. Brief Profile of the Internal Auditor are attached herewith 1) Aud

Read article

UNISEM

UNISEM

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Unisem Agritech (UNISEM): Company Update

Company Update Non- Applicability of Annual Secretarial Compliance Report for the Financial Year ended 31.03.2026 under Regulation 24A of the SEBI (LODR) Regulations, 2015. Unisem Agritech Limited is claiming exemption under Regulation 15(2) of the Chapter IV of SEBI (LODR), Regulations 2015 as: (b) The listed entity which has listed its securities on the SME Exchange. In View of the above, relaxation is provided to SME listed Companies under Reg 15(2) of SEBI(LODR) Regulations, 2015

Read article

UNISEM

UNISEM

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Unisem Agritech (UNISEM): Company Update

Company Update Non- Applicability of Annual Secretarial Compliance Report for the Financial Year ended 31.03.2026 under Regulation 24A of the SEBI (LODR) Regulations, 2015. Unisem Agritech Limited is claiming exemption under Regulation 15(2) of the Chapter IV of SEBI (LODR), Regulations 2015 as: (b) The listed entity which has listed its securities on the SME Exchange. In View of the above, relaxation is provided to SME listed Companies under Reg 15(2) of SEBI(LODR) Regulations, 2015

Read article

SHRICON

SHRICON

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Shricon Industries (SHRICON): Others

Others Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ('SEBI Listing Regulations'), we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. May 28, 2026, has, inter alia: 1. Accepted the resignation of M/s R S Dani & Co., Chartered Accountants, as Statutory Auditor of the Company due to expiration of peer review certificate of his firm and his inability to sign and conduct audit for

Read article

SHRICON

SHRICON

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Shricon Industries (SHRICON): Others

Others Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ('SEBI Listing Regulations'), we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. May 28, 2026, has, inter alia: 1. Accepted the resignation of M/s R S Dani & Co., Chartered Accountants, as Statutory Auditor of the Company due to expiration of peer review certificate of his firm and his inability to sign and conduct audit for

Read article

EMROCK

EMROCK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Emrock (EMROCK): Company Update

Company Update The Board at their Meeting held on today has considered and approved issue on convertible share warrant on preferential basis subject to the approval of members in upcoming EGM in terms of Provision of the companies Act, 2013, SEBI (ICDR) Regulation, 2018 and SEBI (LODR) Regulation 2015 The Board at their Meeting held on today has considered and approved issue on convertible share warrant on preferential basis subject to the approval of members in upcoming EGM in terms of Provis

Read article

RELAXO

RELAXO

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Relaxo Footwears (RELAXO): Company Update

Company Update Intimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Investment upto Rs 2.50 Crore by way of subscription to and/or acquisition of equity shares carrying voting rights in a Special Purpose Vehicle. Intimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Investment upto Rs 2.50 Crore by way of subscription to and/or acquisition of equity shares carrying voting rights in a Special Purpose Vehicle.

Read article

CEMAINFRA

CEMAINFRA

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Cemantic Infra-Tech (CEMAINFRA): Company Update

Company Update Pursuant to Regulation 24A of SEBI (LODR) regulations, 2015, please find attached the Annual Secretarial Compliance Report for the year ended March 31, 2026 signed by CS Ajay Suman Shrivastava, Company Secretary in Practice duly noted by the Board of Directors. Pursuant to Regulation 24A of SEBI (LODR) regulations, 2015, please find attached the Annual Secretarial Compliance Report for the year ended March 31, 2026 signed by CS Ajay Suman Shrivastava, Company Secretary in Practi

Read article

AWL

AWL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

AWL Agri Business (AWL): Company Update

Company Update Disclosure under Regulation 30 of SEBI Listing Regulations.- Execution of definitive agreements for marketing and distribution of sugar under "Madhur" brand Disclosure under Regulation 30 of SEBI Listing Regulations.- Execution of definitive agreements for marketing and distribution of sugar under "Madhur" brand Disclosure under Regulation 30 of SEBI Listing Regulations.- Execution of definitive agreements for marketing and distribution of sugar under "Madhur" brand

Read article

ZYDUSLIFE

ZYDUSLIFE

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Company Update

Company Update Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA.

Read article

ECOSMOBLTY

ECOSMOBLTY

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

ECOS (India) Mobility & Hospitality (ECOSMOBLTY): Board Meeting

Board Meeting 1. Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026, we submit herewith: a) the Auditor's Report on Standalone & Consolidated Financial Results issued by our Statutory Auditors M/s SS Kothari Mehta & Co. LLP, Chartered Accounts b) Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2026 c) Audited Statement of Assets and Liabilities as on March 31, 2026 d)

Read article

ZYDUSLIFE

ZYDUSLIFE

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Press Release

Press Release Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA". Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority

Read article

EXCELINDUS

EXCELINDUS

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Excel Industries Posts FY26 Earnings Call Transcript on BSE

Excel Industries has published the transcript of its earnings call for the quarter and financial year ended March 31, 2026, as per SEBI regulations.

Read article